BNP Paribas Asset Management
AGN

BNP Paribas Asset Management’s Allergan Inc AGN Stock Holding History

BNP Paribas Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-57,575
Closed -$12.2M – 1096
2014
Q4 		$12.2M Sell
57,575
-63,154
-52% -$12.6M 0.1% 264
2014
Q3 		$21.5M Sell
120,729
-248
-0.2% -$41.2K 0.17% 166
2014
Q2 		$20.5M Buy
120,977
+43,683
+57% +$6.8M 0.16% 177
2014
Q1 		$9.59M Sell
77,294
-108,486
-58% -$13.2M 0.07% 291
2013
Q4 		$20.6M Sell
185,780
-319,052
-63% -$30.5M 0.15% 167
2013
Q3 		$45.7M Sell
504,832
-188,064
-27% -$16.9M 0.34% 94
2013
Q2 		$58.4M Buy
+692,896
New +$71.9M 0.43% 59

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

BNP Paribas Asset Management's AGN Position: Q1 2015 in Review

BNP Paribas Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 57,575 shares — an estimated $12.2M sold.

BNP Paribas Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $58.4M in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • BNP Paribas Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • BNP Paribas Asset Management sold 57,575 Allergan Inc shares in Q1 2015, an estimated $12.2M.
  • BNP Paribas Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • BNP Paribas Asset Management's Allergan Inc position peaked at $58.4M in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on BNP Paribas Asset Management's 13F filing for Q1 2015, filed 12 May 2015.